| Heading: |
Health Services: Artificial Intelligence |
| Question ID: |
1812702 |
| UIN: |
59910 |
| House: |
Commons |
| Date tabled: |
2025-06-13 |
| Asking Member ID: |
5111 |
| Asking Member display name: |
Martin Wrigley
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
Martin Wrigley
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that non-deterministic outputs from AI tools used in (a) diagnostics and (b) treatment planning can be (i) explained and (ii) validated. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-06-20 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
In the United Kingdom, the majority of artificial intelligence (AI) products being used in health and social care are regulated as medical devices. This means they are subject to stringent safety, performance, and efficacy requirements, primarily set out ... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |